Author:
Ishihara Yasunobu,Yamada Yoshiharu,Hata Yusuke,Okabe Susumu
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Reference8 articles.
1. Akimoto T, Tsukada K, Yamasaki T, Kojima H, Kasahara A, Akashi A, Yamaguchi K, Oshima Y: Pharmacological studies of an antiinflammatory agent 1-(4-methoxy-6-methyl-2-pyrimidinyl)-3-methyl-5-methoxypyrazole (DA-398). Folia Pharmacol Jpn 65:378?409, 1969
2. Tsurumi K, Nosaki M, Hiramatsu Y, Hayashi M, Fujimura H: Pharmacological studies of 1-(4-methyl-6-methoxy-2-pyrimidinyl)-3-methyl-5-methoxypyrazole. Folia Pharmacol Jpn 65:620?642, 1969
3. Okabe S, Ishihara Y, Inoo H, Tanaka H: Mepirizole-induced duodenal ulcers in rats and their pathogenesis. Dig Dis Sci 27:242?249, 1982
4. Anson ML: The estimation of pepsin, trypsin, papain and cathepsin with hemoglobin. J Gen Physiol 22:79?89, 1938
5. Kent YH, Cardelli RM, Stamler FW. Small intestinal ulcers and intestinal flora in rats given indomethacin. Am J Pathol 54:237?245, 1969
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Biochemical and pharmacological characteristics of a newly synthesized H+-K+ATPase inhibitor, YJA20379-1, 2-amino-4,5-dihydro-8-phenylimidazole [2,1-b]thiazolo[5,4-g]benzothiazole;Canadian Journal of Physiology and Pharmacology;1999-06-15
2. Biochemical and pharmacological characteristics of a newly synthesized H+-K+ ATPase inhibitor, YJA20379-1, 2-amino-4,5-dihydro-8-phenylimidazole [2,1-b]thiazolo[5,4-g]benzothiazole;Canadian Journal of Physiology and Pharmacology;1999
3. Complications of combined intraoperative radiation (IORT) and external radiation (ERT) of the upper abdomen: an experimental model;Radiotherapy and Oncology;1996-03
4. Acid secretory and duodenal ulcerogenic responses induced by mepirizole in anesthetized rats;Digestive Diseases and Sciences;1994-08
5. Histologic and Ultrastructural Features of Experimental Duodenal Ulcers in Sprague-Dawley Rats;Experimental and Molecular Pathology;1993-10